Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3,4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine
Open Access
- 1 August 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (8), 1735-1743
- https://doi.org/10.1038/sj.bjp.0701325
Abstract
1 The mechanism underlying 5‐hydroxytryptamine (5‐HT) and/or dopamine release induced by (+)‐amphetamine ((+)‐Amph), 3,4‐methylendioxymethamphetamine (MDMA), p‐chloroamphetamine (pCA) and (+)‐fenfluramine ((+)‐Fen) was investigated in rat brain superfused synaptosomes preloaded with the 3H neurotransmitters. 2 Their rank order of potency for [3H]‐5‐HT‐releasing activity was the same as for inhibition of 5‐HT uptake (pCAMDMA(+)‐Fen>>(+)‐Amph). Similarly, their rank order as [3H]‐dopamine releasers and dopamine uptake inhibitors was the same ((+)‐Amph>>pCA=MDMA>>(+)‐Fen). We also confirmed that the release induced by these compounds was prevented by selective transporter inhibitors (indalpine or nomifensine). 3 [3H]‐5‐HT and/or [3H]‐dopamine release induced by all these compounds was partially (31–80%), but significantly Ca2+‐dependent. Lack of extracellular Ca2+ did not alter uptake mechanisms nor did it modify the carrier‐dependent dopamine‐induced [3H]‐dopamine release. (+)‐Amph‐induced [3H]‐dopamine release and pCA‐ and MDMA‐induced [3H]‐5‐HT release were significantly inhibited by ω‐agatoxin‐IVA, a specific blocker of P‐type voltage‐operated Ca2+‐channels, similar to the previous results on (+)‐Fen‐induced [3H]‐5‐HT release. 4 Methiothepin inhibited the Ca2+‐dependent component of (+)‐Amph‐induced [3H]‐dopamine release with high potency (70 nM), as previously found with (+)‐Fen‐induced [3H]‐5‐HT release. The inhibitory effect of methiothepin was not due to its effects as a transporter inhibitor or Ca2+‐channel blocker and is unlikely to be due to its antagonist properties on 5‐HT1/2, dopamine or any other extracellular receptor. 5 These results indicate that the release induced by these compounds is both ‘carrier‐mediated’ and Ca2+‐dependent (possibly exocytotic‐like), with the specific carrier allowing the amphetamines to enter the synaptosome. The Ca2+‐dependent release is mediated by Ca2+‐influx (mainly through P‐type Ca2+‐channels), possibly triggered by the drug interacting with an unknown intracellular target, affected by methiothepin, common to both 5‐HT and dopamine synaptosomes. British Journal of Pharmacology (1997) 121, 1735–1743; doi:10.1038/sj.bjp.0701325Keywords
This publication has 41 references indexed in Scilit:
- Channels in transportersCurrent Opinion in Neurobiology, 1996
- In vivo and in vitro interaction of flunarizine with ?-fenfluramine serotonergic effectsPharmacology Biochemistry and Behavior, 1996
- Ca2+‐Dependent Enhancement of [3H]Dopamine Uptake in Rat Striatum: Possible Involvement of Calmodulin‐Dependent KinasesJournal of Neurochemistry, 1995
- Conducting states of a mammalian serotonin transporterNeuron, 1994
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- [3H]Dopamine Depletion from Osmotically Defined Storage Sites: Effects of Reserpine, 53 mMKC1, andd-AmphetamineJournal of Neurochemistry, 1983
- Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endingsNeurochemistry International, 1981
- II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in manLife Sciences, 1981
- RELEASE AND EXCHANGE STUDIES RELATING TO THE SYNAPTOSOMAL UPTAKE OF GABAJournal of Neurochemistry, 1975
- Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptakeNature, 1974